{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:25:43Z","timestamp":1790792743941,"version":"4.1.0"},"reference-count":61,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1,15]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Genetic elimination of the coagulation transglutaminase fXIII limits arthritis incidence and severity in mice. FXIII supports arthritis pathogenesis through distinct mechanisms linked to joint inflammation and osteoclastogenesis.<\/jats:p>","DOI":"10.1182\/blood-2014-08-594754","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T05:57:25Z","timestamp":1413957445000},"page":"427-437","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion"],"prefix":"10.1182","volume":"125","author":[{"given":"Harini","family":"Raghu","sequence":"first","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cruz","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Rewerts","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malinda D.","family":"Frederick","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Thornton","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Mullins","sequence":"additional","affiliation":[{"name":"Division of Hematology, Cincinnati Children\u2019s Hospital Research Foundation, Cincinnati, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Schoenecker","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Degen","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Flick","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111818082241900_B1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2009.175","article-title":"Promising bone-related therapeutic targets for rheumatoid arthritis.","volume":"5","author":"Choi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"9 Suppl B","key":"2019111818082241900_B2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.18553\/jmcp.2011.17.s9-b.S14","article-title":"Biologic agents in rheumatoid arthritis: an update for managed care professionals.","volume":"17","author":"Agarwal","year":"2011","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"2019111818082241900_B3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-1229(92)90008-C","article-title":"Pathways of coagulation activation in situ in rheumatoid synovial tissue.","volume":"63","author":"Zacharski","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"issue":"9","key":"2019111818082241900_B4","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.10498","article-title":"Extravascular coagulation and the plasminogen activator\/plasmin system in rheumatoid arthritis.","volume":"46","author":"Busso","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2019111818082241900_B5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrrheum.2012.184","article-title":"Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"2019111818082241900_B6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1172\/JCI11064","article-title":"Amelioration of collagen-induced arthritis by thrombin inhibition.","volume":"107","author":"Marty","year":"2001","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111818082241900_B7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.21001","article-title":"Reduction of arthritis severity in protease-activated receptor-deficient mice.","volume":"52","author":"Yang","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2019111818082241900_B8","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111818082241900_B9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2010.04070.x","article-title":"Factor XIII: novel structural and functional aspects.","volume":"9","author":"Kom\u00e1romi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111818082241900_B10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2011.11.040","article-title":"Factor XIII, clot structure, thrombosis.","volume":"129","author":"Bagoly","year":"2012","journal-title":"Thromb Res"},{"issue":"3","key":"2019111818082241900_B11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20120233","article-title":"Substrates of Factor XIII-A: roles in thrombosis and wound healing.","volume":"124","author":"Richardson","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2019111818082241900_B12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH05-04-0291","article-title":"Impaired wound healing in factor XIII deficient mice.","volume":"94","author":"Inbal","year":"2005","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111818082241900_B13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0029-1225765","article-title":"Factor XIII Deficiency.","volume":"35","author":"Karimi","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2019111818082241900_B14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2008.02938.x","article-title":"Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function.","volume":"6","author":"Palumbo","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"16","key":"2019111818082241900_B15","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1101\/gad.9.16.2020","article-title":"Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.","volume":"9","author":"Suh","year":"1995","journal-title":"Genes Dev"},{"issue":"1","key":"2019111818082241900_B16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2110","article-title":"Cells of the synovium in rheumatoid arthritis. Osteoclasts.","volume":"9","author":"Schett","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2019111818082241900_B17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.105.098020","article-title":"A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.","volume":"318","author":"Medicherla","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2019111818082241900_B18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ydbio.2014.06.020","article-title":"The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth.","volume":"393","author":"Touaitahuata","year":"2014","journal-title":"Dev Biol"},{"issue":"1","key":"2019111818082241900_B19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.thromres.2010.04.007","article-title":"Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.","volume":"126","author":"Kwasny-Krochin","year":"2010","journal-title":"Thromb Res"},{"issue":"12","key":"2019111818082241900_B20","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/j.1538-7836.2003.00462.x","article-title":"Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways.","volume":"1","author":"So","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111818082241900_B21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI2312","article-title":"Exacerbation of antigen-induced arthritis in urokinase-deficient mice.","volume":"102","author":"Busso","year":"1998","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111818082241900_B22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2174\/138920111798281144","article-title":"Targeting the coagulation factor fibrinogen for arthritis therapy.","volume":"12","author":"Raghu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"2019111818082241900_B23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4049\/jimmunol.0901639","article-title":"Autoimmunity against fibrinogen mediates inflammatory arthritis in mice.","volume":"184","author":"Ho","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"2019111818082241900_B24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/rheumatology\/keg021","article-title":"Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis.","volume":"42","author":"S\u00e1nchez-Pernaute","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"2019111818082241900_B25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions.","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111818082241900_B26","first-page":"177","article-title":"The roles of fibrinogen and fibrin in hemostasis and thrombosis.","volume":"29","author":"Mosesson","year":"1992","journal-title":"Semin Hematol"},{"issue":"2","key":"2019111818082241900_B27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12455","article-title":"The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.","volume":"12","author":"Hethershaw","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111818082241900_B28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/153537020422901104","article-title":"Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.","volume":"229","author":"Flick","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"2019111818082241900_B29","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI20741","article-title":"Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2\/Mac-1 is critical for host inflammatory response in vivo.","volume":"113","author":"Flick","year":"2004","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111818082241900_B30","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4049\/jimmunol.154.4.1879","article-title":"Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation.","volume":"154","author":"Perez","year":"1995","journal-title":"J Immunol"},{"issue":"3","key":"2019111818082241900_B31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.yjmcc.2004.06.001","article-title":"Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.","volume":"37","author":"Mar\u00edn","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2019111818082241900_B32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"issue":"3","key":"2019111818082241900_B33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0006-291X(91)90669-X","article-title":"Osteopontin, a substrate for transglutaminase and factor XIII activity.","volume":"177","author":"Prince","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019111818082241900_B34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbrc.2004.02.124","article-title":"Osteopontin as a positive regulator in the osteoclastogenesis of arthritis.","volume":"316","author":"Ishii","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2019111818082241900_B35","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.10143","article-title":"Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis.","volume":"46","author":"Ohshima","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111818082241900_B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI17778","article-title":"Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.","volume":"112","author":"Yamamoto","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111818082241900_B37","first-page":"240","article-title":"Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.","volume":"26","author":"Ainola","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2019111818082241900_B38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation.","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"2","key":"2019111818082241900_B39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/S0100-879X2005000200004","article-title":"RANK, RANKL and osteoprotegerin in arthritic bone loss.","volume":"38","author":"Bezerra","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"2019111818082241900_B40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X12438080","article-title":"The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis.","volume":"4","author":"Geusens","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"11","key":"2019111818082241900_B41","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2019111818082241900_B42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"Osteoimmunology: interplay between the immune system and bone metabolism.","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"2019111818082241900_B43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"issue":"4","key":"2019111818082241900_B44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.","volume":"161","author":"Romas","year":"2002","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111818082241900_B45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2006.06.098","article-title":"Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody.","volume":"347","author":"Kamijo","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2019111818082241900_B46","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"issue":"6","key":"2019111818082241900_B47","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2879","article-title":"RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.","volume":"11","author":"Stolina","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2019111818082241900_B48","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.24445","article-title":"Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.","volume":"60","author":"Hofbauer","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6759","key":"2019111818082241900_B49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"12","key":"2019111818082241900_B50","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"issue":"5","key":"2019111818082241900_B51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2007-999043","article-title":"Tissue transglutaminase and factor XIII in cartilage and bone remodeling.","volume":"22","author":"Aeschlimann","year":"1996","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2019111818082241900_B52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.matbio.2005.11.001","article-title":"Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.","volume":"25","author":"Al-Jallad","year":"2006","journal-title":"Matrix Biol"},{"issue":"8","key":"2019111818082241900_B53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1590\/S0100-879X2012007500060","article-title":"Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line.","volume":"45","author":"Yin","year":"2012","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"2019111818082241900_B54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/MCB.21.1.148-155.2001","article-title":"Gene disruption of tissue transglutaminase.","volume":"21","author":"De Laurenzi","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"23","key":"2019111818082241900_B55","doi-asserted-by":"crossref","first-page":"20673","DOI":"10.1074\/jbc.M010846200","article-title":"Targeted inactivation of Gh\/tissue transglutaminase II.","volume":"276","author":"Nanda","year":"2001","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111818082241900_B56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1369\/jhc.6A7091.2007","article-title":"Expression and localization of plasma transglutaminase factor XIIIA in bone.","volume":"55","author":"Nakano","year":"2007","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"2019111818082241900_B57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cellimm.2004.04.007","article-title":"Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.","volume":"228","author":"S\u00e1rv\u00e1ry","year":"2004","journal-title":"Cell Immunol"},{"issue":"8","key":"2019111818082241900_B58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejcb.2009.04.002","article-title":"Possible role for cellular FXIII in monocyte-derived dendritic cell motility.","volume":"88","author":"Jayo","year":"2009","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"2019111818082241900_B59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2004.10.006","article-title":"Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.","volume":"119","author":"AbdAlla","year":"2004","journal-title":"Cell"},{"issue":"3","key":"2019111818082241900_B60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/labinvest.2010.186","article-title":"Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.","volume":"91","author":"Elli","year":"2011","journal-title":"Lab Invest"},{"issue":"2","key":"2019111818082241900_B61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2012.08.009","article-title":"Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.","volume":"145","author":"Oh","year":"2012","journal-title":"Clin Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/3\/427\/1344458\/427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/3\/427\/1344458\/427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:55:30Z","timestamp":1689598530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/125\/3\/427\/33922\/Transglutaminase-factor-XIII-promotes-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-08-594754","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]}}}